Synapse - Pedram Razavi

Results (175)

Non-canonical, clinical ESR1 mutations promote resistance to antiestrogen therapies

Meeting Abstract

Toy, W.; Carlson, K. E.; Martin, T. A.; Razavi, P.; Berger, M.; Baselga, J.; Greene, G.; Katzenellenbogen, J.; Chandarlapaty, S.
Cancer Research (2019)

Fulltext@MSK | Save

Double PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer

Meeting Abstract

Vasan, N.; Razavi, P.; Johnson, J. L.; Shao, H.; Reznik, E.; Smith, M. L.; Sebra, R.; Cantley, L. C.; Scaltriti, M.; Baselga, J.
Annals of Oncology (2019)

Fulltext@MSK | Save

Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: Results from the Actionable Genome Consortium

Journal Article

Li, B. T.; Janku, F.; Jung, B.; Hou, C.; Madwani, K.; Alden, R.; Razavi, P.; Reis-Filho, J. S.; Shen, R.; Isbell, J. M.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Cyclin e mRNA: Assessing cyclin-dependent kinase (CDK) activation state to elucidate breast cancer resistance to CDK4/6 Inhibitors

Editorial

Chandarlapaty, S.; Razavi, P.
Journal of Clinical Oncology (2019)

Fulltext@MSK | Save

Next-generation sequencing–based assessment of JAK2, PD-L1, and PD-L2 copy number alterations at 9p24.1 in breast cancer: Potential implications for clinical management

Journal Article

Gupta, S.; Vanderbilt, C. M.; Cotzia, P.; Arias-Stella, J. A. 3rd; Chang, J. C.; Zehir, A.; Benayed, R.; Nafa, K.; Razavi, P.; Hyman, D. M.; more...
Journal of Molecular Diagnostics (2019)

Fulltext@MSK | Save

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Research Letter

Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
Nature Genetics (2019)

Fulltext@MSK | Save

Immunohistochemical analysis of estrogen receptor in breast cancer with ESR1 mutations detected by hybrid capture-based next-generation sequencing

Journal Article

Ross, D. S.; Zehir, A.; Brogi, E.; Konno, F.; Krystel-Whittemore, M.; Edelweiss, M.; Berger, M. F.; Toy, W.; Chandarlapaty, S.; Razavi, P.; more...
Modern Pathology (2019)

Fulltext@MSK | Save

Refining actionable HER2 alterations in lung cancers through next generation sequencing (NGS)

Meeting Abstract

Xu, C.; Myers, M.; Buonocore, D. J.; Razavi, P.; Shen, R.; Lai, W. C. V.; Smyth, L. M.; Zheng, T.; Ni, A.; Solit, D. B.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Estimation of tumor-derived mutant allele fractions in cfDNA by shallow whole genome sequencing and fragment size analysis

Meeting Abstract

Yang, J.; Marass, F.; Ulz, P.; Shady, M.; Cheng, M. L.; Kothari, P.; Gedvilaite, E.; Somnay, S.; Shukla, N.; Modak, S.; more...
Cancer Research (2018)

Fulltext@MSK | Save

Development and optimization of a comprehensive high-sensitivity NGS cancer assay and bioinformatics pipeline for plasma cfDNA profiling

Meeting Abstract

Patel, J.; Hasan, M.; Meng, F.; Jing, X.; Perera, D.; Reichel, J.; Gedvilaite, E.; Yang, J.; Shady, M.; Raj, S.; more...
Cancer Research (2018)

Fulltext@MSK | Save